Kim Dohun, Kim Hong Kwan, Kim Seok-Hyung, Lee Ho Yun, Cho Jong Ho, Choi Yong Soo, Kim Kwhanmien, Kim Jhingook, Zo Jae Ill, Shim Young Mog
Department of Thoracic and Cardiovascular Surgery, Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul, Korea.
Department of Thoracic and Cardiovascular Surgery, Chungbuk National University and Chungbuk National University Hospital, Cheongju, Korea.
J Thorac Dis. 2018 Jan;10(1):388-397. doi: 10.21037/jtd.2017.12.38.
We investigated the prognostic value of the International Association for the Study of Lung Cancer (IASLC)/American Thoracic Society (ATS)/European Respiratory Society (ERS) classification and assessed the relationship between pathologic invasiveness and tumor disappearance rate (TDR) in lung adenocarcinoma with ground-glass opacity (GGO).
We reviewed data from 202 consecutive patients operated on between 2000 and 2009 for clinical T1-2N0 lung adenocarcinoma with GGO and reclassified their histologic subtypes according to the IASLC/ATS/ERS classification. Thirty-nine patients had adenocarcinoma in situ (AIS), 29 minimally invasive adenocarcinoma (MIA), 75 lepidic predominant invasive adenocarcinoma (LPA), and 59 non-lepidic predominant invasive adenocarcinoma (NLPA). Survival outcomes were compared according to histologic subtype and TDR.
The mean age was 58 years and 101 patients (50%) were male. Lobectomy was performed in 161 patients (79.7%), wedge resection in 34 (16.8%), and segmentectomy in 7 (3.5%). Patients with AIS, MIA, and LPA had significantly smaller tumor sizes, earlier pathologic T stages, and lower incidences of lymphatic/pleural invasion than those with NLPA. The 5-year recurrence-free survival (RFS) rates were 95.1%, 94.5%, and 87.6% in the AIS + MIA, LPA, and NLPA groups, respectively (P=0.029). Tumors with a TDR>75% were associated with lepidic predominant histologic subtype and less pathologic invasiveness. The 5-year RFS rates were 97.4% in tumors with a TDR >75% and 87.8% in tumors with a TDR ≤75% (P=0.0009).
Histologic subtype according to the IASLC/ATS/ERS classification and TDR both correlated with pathologic invasiveness and predicted survival in patients with lung adenocarcinoma with GGO.
我们研究了国际肺癌研究协会(IASLC)/美国胸科学会(ATS)/欧洲呼吸学会(ERS)分类的预后价值,并评估了肺腺癌磨玻璃影(GGO)的病理侵袭性与肿瘤消失率(TDR)之间的关系。
我们回顾了2000年至2009年间接受手术的202例临床T1-2N0肺腺癌伴GGO患者的数据,并根据IASLC/ATS/ERS分类对其组织学亚型进行重新分类。39例为原位腺癌(AIS),29例为微浸润腺癌(MIA),75例为贴壁为主型浸润性腺癌(LPA),59例为非贴壁为主型浸润性腺癌(NLPA)。根据组织学亚型和TDR比较生存结果。
平均年龄为58岁,101例患者(50%)为男性。161例患者(79.7%)行肺叶切除术,34例(16.8%)行楔形切除术,7例(3.5%)行肺段切除术。与NLPA患者相比,AIS、MIA和LPA患者的肿瘤大小明显更小,病理T分期更早,淋巴/胸膜侵犯发生率更低。AIS+MIA、LPA和NLPA组的5年无复发生存率(RFS)分别为95.1%、94.5%和87.6%(P=0.029)。TDR>75%的肿瘤与贴壁为主型组织学亚型和较低的病理侵袭性相关。TDR>75%的肿瘤5年RFS率为97.4%,TDR≤75%的肿瘤为87.8%(P=0.0009)。
根据IASLC/ATS/ERS分类的组织学亚型和TDR均与肺腺癌伴GGO患者的病理侵袭性相关,并可预测生存情况。